Product Code: CHFI
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
The new normal leads to demand for analgesics
Analgesics suffers from lack of innovation
Challengers leverage COVID-19 to gain value share
PROSPECTS AND OPPORTUNITIES
General decline over forecast period
E-commerce and OTC liberalisation
Possible upcoming switches
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Successfully combating the common cold due to COVID-19 restrictions leads to fall in value sales
Consumers reach for the biggest names
Decongestants buck the downward trend, while more time in the countryside lowers value sales of antihistamines/allergy remedies
PROSPECTS AND OPPORTUNITIES
Moderate recovery over forecast period
Antihistamines largely dependent on weather
Possible reregulation would have significant impact on competitive landscape
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Return to normality for diarrhoeal remedies
Leaders' shares steadier than previously, amid general fall in demand
Paediatric laxatives niche shows potential
PROSPECTS AND OPPORTUNITIES
Increasing consumer attention to digestive health
Competition to strengthen within leading product area laxatives
No significant innovation over forecast period
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Dermatologicals sales little affected by pandemic
Leading companies show stability in the face of COVID-19
Hair loss treatment perform strongly
PROSPECTS AND OPPORTUNITIES
Normalisation rather than innovation
Competing with skin care a future possibility
Ageing population and climate change support growth across the forecast period
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Smoking less and less attractive to consumers
Snus not an NRT substitute
Market remains effective duopoly
PROSPECTS AND OPPORTUNITIES
Lower value growth than review period
Stamp down on e-vapour products boosts value sales
Little innovation expected
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
With fear around COVID-19 abating, value growth slows
Consumer loyalty is lower in sleep aids
Low consumer loyalty
PROSPECTS AND OPPORTUNITIES
Healthy value growth over forecast period
Modern grocery retailers to awaken more Finns to sleep aids, while e-commerce is also set to strengthen
Players continue to innovate
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Purchasing patterns return to pre pandemic levels
Competition heating up in standard eye care
Fierce competition eats away at margins
PROSPECTS AND OPPORTUNITIES
Increased time spend on screens supports value sales of standard eye care
Standard eye care set to be boosted by the ageing population
Allergy eye care to stagnate over forecast period
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Wound care returns to value growth
Competition is heating up
Slow change, rather than revolution
PROSPECTS AND OPPORTUNITIES
Moderate growth over forecast period
Growth potential exists in complete care solutions and artistic designs
Economic contraction could see private label accelerate
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sales stagnate after COVID-19 windfall
Challenges for leader Orion in a crowded category
Fierce competition as landscape matures
PROSPECTS AND OPPORTUNITIES
Expended growth potential
Shifting attitudes, but little change in demand
Vitamins combine rather than compete with lifestyle and dietary supplements
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sales stagnate after COVID-19 windfall
Verman is active in responding to current trends in crowded category
Fish oils/omega fatty acids loses popularity
PROSPECTS AND OPPORTUNITIES
Dietary supplements register healthy value growth over forecast period
Herbal/traditional dietary supplements, minerals see strong growth
To combine with lifestyle changes and Vitamins
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Continued home seclusion and stability
Orkla and Midsona remain at the top, but others are beginning to challenge
Finns prefer lifestyle changes and improved diet over meal replacements
PROSPECTS AND OPPORTUNITIES
Stagnant growth over forecast period
Slimming teas and supplement nutrition drinks resist downturn
E-commerce continues to grow at healthy pace
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Social media and e-commerce help drive sales
Long-time leaders in danger of being overtaken by competitors
Protein/energy bars continues to be top performer despite pandemic
PROSPECTS AND OPPORTUNITIES
Bars and non-protein products to lead growth
Increased popularity of outdoor activities dampens value growth
Growth supported by dietary trends
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Value sales return to more normal consumption patterns
Crowded product area headed by Cloetta
Herbal/traditional products gain acceptance
PROSPECTS AND OPPORTUNITIES
Healthy value growth over forecast period
"Green" trend needs to be capitalised on more
Increased segmentation way of standing out from the crowd
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN FINLAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Paediatric products remain less affected by pandemic
GSK and Orion maintain the leading ranks, boosted by consumers now relying more on the big names
Digestive remedies and analgesics benefit from normalisation
PROSPECTS AND OPPORTUNITIES
Acetaminophen to remain more popular than Ibuprofen
Demographic trends to dominate with normalisation
Shift towards natural products over forecast period
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
